Enanta Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Enanta Pharmaceuticals

05/08/2024 22:11

* Enanta Pharmaceuticals Inc  ENTA.OQ  reported a quarterly
adjusted loss of $1.07​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of $-1.86.  The mean expectation of seven analysts
for the quarter was for a loss of $1.45 per share. Wall Street
expected results to range from $-1.73 to $-1.18 per share.
    * Revenue fell 4.9% to $17.97 million from a year ago;
analysts
expected $17.18 million. 
    * Enanta Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.07​.
    * The company reported a quarterly loss of $22.66 million.
    * Enanta Pharmaceuticals Inc shares had risen by 7.2% this
quarter and gained 47.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 14.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "hold."

Wall Street's median 12-month price target for Enanta
Pharmaceuticals Inc is $22.00 
This summary was machine generated from LSEG data August 5 at
09:11 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.45          -1.07          Beat
 Mar. 31 2024      -1.30          -1.47          Missed
 Dec. 31 2023      -1.19          -1.58          Missed
 Sep. 30 2023      -2.15          -1.33          Beat